Envoy Medical, Inc.

Anzu Special Acquisition Corp I, trading under the ticker ANZU, is a blank-check company that completed its initial public offering in 2021, targeting opportunities in the healthcare and medical technology sector. The SPAC filed a Form 10-Q with the SEC on August 18, 2021, reflecting its operating status as a pre-combination vehicle. Anzu Special Acquisition Corp I identified Envoy Medical, Inc. as its business combination target; Envoy Medical is a medical device company focused on fully implantable hearing technology, including its Esteem active middle ear implant platform. The SPAC was sponsored by Anzu SPAC Partners. Visit SpacDesk and sign up for full data, filings, and deal timelines on ANZU and hundreds of other SPAC transactions.